Literature DB >> 22706543

Regorafenib in metastatic colorectal cancer.

Axel Grothey1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22706543

Source DB:  PubMed          Journal:  Clin Adv Hematol Oncol        ISSN： 1543-0790


× No keyword cloud information.
  3 in total

1.  A phase 1 dose-escalation study of NEO-102 in patients with refractory colon and pancreatic cancer.

Authors:  Muhammad S Beg; Nilofer S Azad; Sandip P Patel; Jose Torrealba; Sharon Mavroukakis; Melony A Beatson; Xue Ping Wang; Philip M Arlen; Michael A Morse
Journal:  Cancer Chemother Pharmacol       Date:  2016-07-23       Impact factor: 3.333

2.  Personalizing colon cancer therapeutics: targeting old and new mechanisms of action.

Authors:  Christina Leah B Kline; Wafik S El-Deiry
Journal:  Pharmaceuticals (Basel)       Date:  2013-08-21

Review 3.  Regorafenib: Adding to the Armamentarium for Refractory Colorectal Cancer and GIST.

Authors:  Danielle Roman; Rachelle Whiteside
Journal:  J Adv Pract Oncol       Date:  2013-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.